Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
America must win the AI race — and prepare for the worst

Related Posts

WESTERN COPPER AND GOLD PROVIDES POSITIVE METALLURGICAL UPDATE

February 14, 2025

Ole Hansen: Gold, Silver, Copper, Oil — Prices,...

April 15, 2025

Providence Gold Mines: Unlocking Untapped, High-grade Gold Deposits...

October 8, 2025

Coelacanth Announces 2024 Year-End Reserves

April 25, 2025

Gold Retreats, Equities Down as Fed Leaves Rates...

July 31, 2025

Nuclear Fuels Acquires TenSleep Uranium Project with Athabasca...

March 4, 2025

Standard Uranium: Advancing An Extensive Uranium Portfolio in...

November 13, 2025

Providence Extends Private Placement

March 29, 2025

Oil Price and Inflation: What’s the Correlation?

May 15, 2025

NVIDIA Facing Weak Demand for New Chip as...

September 17, 2025

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio
  • MIKE DAVIS: Why DC’s Trump-hating Judge Boasberg must be impeached
  • State Department stays quiet as Albania reinstates deputy PM accused of corruption
  • Maduro trapped with few retaliation options after Trump admin seizes Venezuelan oil tanker

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics

    December 14, 2025
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    December 14, 2025
  • MIKE DAVIS: Why DC’s Trump-hating Judge Boasberg must be impeached

    December 14, 2025
  • State Department stays quiet as Albania reinstates deputy PM accused of corruption

    December 14, 2025
  • Maduro trapped with few retaliation options after Trump admin seizes Venezuelan oil tanker

    December 14, 2025
  • State Department stays quiet as Albania reinstates deputy prime minister accused of corruption

    December 14, 2025

Editors’ Picks

  • 1

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 2

    Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

    September 19, 2025
  • 3

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 4

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 5

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 6

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
  • 7

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
Promotion Image

banner

Categories

  • Business (602)
  • Investing (2,628)
  • Politics (3,181)
  • Stocks (962)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: bullhedging.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2025 bullhedging.com | All Rights Reserved